Table of Content

1 Market Overview

• 1.1 Product Definition and Market Characteristics
• 1.2 Global Neuromuscular Disease Therapeutics Market Size
• 1.3 Market Segmentation
• 1.4 Global Macroeconomic Analysis
• 1.5 SWOT Analysis

2. Market Dynamics

• 2.1 Market Drivers
• 2.2 Market Constraints and Challenges
• 2.3 Emerging Market Trends
• 2.4 Impact of COVID-19
  • 2.4.1 Short-term Impact
  • 2.4.2 Long-term Impact

3 Associated Industry Assessment

• 3.1 Supply Chain Analysis
• 3.2 Industry Active Participants
  • 3.2.1 Suppliers of Raw Materials
  • 3.2.2 Key Distributors/Retailers
• 3.3 Alternative Analysis
• 3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

• 4.1 Industry Leading Players
• 4.2 Industry News
  • 4.2.1 Key Product Launch News
  • 4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

• 5.1 Sanofi
  • 5.1.1 Sanofi Company Profile
  • 5.1.2 Sanofi Business Overview
  • 5.1.3 Sanofi Neuromuscular Disease Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.1.4 Sanofi Neuromuscular Disease Therapeutics Products Introduction
• 5.2 PTC Therapeutics Inc
  • 5.2.1 PTC Therapeutics Inc Company Profile
  • 5.2.2 PTC Therapeutics Inc Business Overview
  • 5.2.3 PTC Therapeutics Inc Neuromuscular Disease Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.2.4 PTC Therapeutics Inc Neuromuscular Disease Therapeutics Products Introduction
• 5.3 Sarepta Therapeutics Inc
  • 5.3.1 Sarepta Therapeutics Inc Company Profile
  • 5.3.2 Sarepta Therapeutics Inc Business Overview
  • 5.3.3 Sarepta Therapeutics Inc Neuromuscular Disease Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.3.4 Sarepta Therapeutics Inc Neuromuscular Disease Therapeutics Products Introduction
• 5.4 Biogen Inc
  • 5.4.1 Biogen Inc Company Profile
  • 5.4.2 Biogen Inc Business Overview
  • 5.4.3 Biogen Inc Neuromuscular Disease Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.4.4 Biogen Inc Neuromuscular Disease Therapeutics Products Introduction
• 5.5 Novartis AG
  • 5.5.1 Novartis AG Company Profile
  • 5.5.2 Novartis AG Business Overview
  • 5.5.3 Novartis AG Neuromuscular Disease Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.5.4 Novartis AG Neuromuscular Disease Therapeutics Products Introduction

6 Market Analysis and Forecast, By Product Types

• 6.1 Global Neuromuscular Disease Therapeutics Sales, Revenue and Market Share by Types (2015-2020)
  • 6.1.1 Global Neuromuscular Disease Therapeutics Sales and Market Share by Types (2015-2020)
  • 6.1.2 Global Neuromuscular Disease Therapeutics Revenue and Market Share by Types (2015-2020)
  • 6.1.3 Global Neuromuscular Disease Therapeutics Price by Types (2015-2020)
• 6.2 Global Neuromuscular Disease Therapeutics Market Forecast by Types (2020-2025)
  • 6.2.1 Global Neuromuscular Disease Therapeutics Market Forecast Sales and Market Share by Types (2020-2025)
  • 6.2.2 Global Neuromuscular Disease Therapeutics Market Forecast Revenue and Market Share by Types (2020-2025)
• 6.3 Global Neuromuscular Disease Therapeutics Sales, Price and Growth Rate by Types (2015-2020)
  • 6.3.1 Global Neuromuscular Disease Therapeutics Sales, Price and Growth Rate of Biologics
  • 6.3.2 Global Neuromuscular Disease Therapeutics Sales, Price and Growth Rate of Small Molecules
• 6.4 Global Neuromuscular Disease Therapeutics Market Revenue and Sales Forecast, by Types (2020-2025)
  • 6.4.1 Biologics Market Revenue and Sales Forecast (2020-2025)
  • 6.4.2 Small Molecules Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

• 7.1 Global Neuromuscular Disease Therapeutics Sales, Revenue and Market Share by Applications (2015-2020)
  • 7.1.1 Global Neuromuscular Disease Therapeutics Sales and Market Share by Applications (2015-2020)
  • 7.1.2 Global Neuromuscular Disease Therapeutics Revenue and Market Share by Applications (2015-2020)
• 7.2 Global Neuromuscular Disease Therapeutics Market Forecast by Applications (2020-2025)
  • 7.2.1 Global Neuromuscular Disease Therapeutics Market Forecast Sales and Market Share by Applications (2020-2025)
  • 7.2.2 Global Neuromuscular Disease Therapeutics Market Forecast Revenue and Market Share by Applications (2020-2025)
• 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  • 7.3.1 Global Neuromuscular Disease Therapeutics Revenue, Sales and Growth Rate of Hospital (2015-2020)
  • 7.3.2 Global Neuromuscular Disease Therapeutics Revenue, Sales and Growth Rate of Research Institute (2015-2020)
  • 7.3.3 Global Neuromuscular Disease Therapeutics Revenue, Sales and Growth Rate of Others (2015-2020)
• 7.4 Global Neuromuscular Disease Therapeutics Market Revenue and Sales Forecast, by Applications (2020-2025)
  • 7.4.1 Hospital Market Revenue and Sales Forecast (2020-2025)
  • 7.4.2 Research Institute Market Revenue and Sales Forecast (2020-2025)
  • 7.4.3 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

• 8.1 Global Neuromuscular Disease Therapeutics Sales by Regions (2015-2020)
• 8.2 Global Neuromuscular Disease Therapeutics Market Revenue by Regions (2015-2020)
• 8.3 Global Neuromuscular Disease Therapeutics Market Forecast by Regions (2020-2025)

9 North America Neuromuscular Disease Therapeutics Market Analysis

• 9.1 Market Overview and Prospect Analysis
• 9.2 North America Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)
• 9.3 North America Neuromuscular Disease Therapeutics Market Revenue and Growth Rate (2015-2020)
• 9.4 North America Neuromuscular Disease Therapeutics Market Forecast
• 9.5 The Influence of COVID-19 on North America Market
• 9.6 North America Neuromuscular Disease Therapeutics Market Analysis by Country
  • 9.6.1 U.S. Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 9.6.2 Canada Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 9.6.3 Mexico Neuromuscular Disease Therapeutics Sales and Growth Rate

10 Europe Neuromuscular Disease Therapeutics Market Analysis

• 10.1 Market Overview and Prospect Analysis
• 10.2 Europe Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)
• 10.3 Europe Neuromuscular Disease Therapeutics Market Revenue and Growth Rate (2015-2020)
• 10.4 Europe Neuromuscular Disease Therapeutics Market Forecast
• 10.5 The Influence of COVID-19 on Europe Market
• 10.6 Europe Neuromuscular Disease Therapeutics Market Analysis by Country
  • 10.6.1 Germany Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 10.6.2 United Kingdom Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 10.6.3 France Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 10.6.4 Italy Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 10.6.5 Spain Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 10.6.6 Russia Neuromuscular Disease Therapeutics Sales and Growth Rate

11 Asia-Pacific Neuromuscular Disease Therapeutics Market Analysis

• 11.1 Market Overview and Prospect Analysis
• 11.2 Asia-Pacific Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)
• 11.3 Asia-Pacific Neuromuscular Disease Therapeutics Market Revenue and Growth Rate (2015-2020)
• 11.4 Asia-Pacific Neuromuscular Disease Therapeutics Market Forecast
• 11.5 The Influence of COVID-19 on Asia Pacific Market
• 11.6 Asia-Pacific Neuromuscular Disease Therapeutics Market Analysis by Country
  • 11.6.1 China Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 11.6.2 Japan Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 11.6.3 South Korea Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 11.6.4 Australia Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 11.6.5 India Neuromuscular Disease Therapeutics Sales and Growth Rate

12 South America Neuromuscular Disease Therapeutics Market Analysis

• 12.1 Market Overview and Prospect Analysis
• 12.2 South America Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)
• 12.3 South America Neuromuscular Disease Therapeutics Market Revenue and Growth Rate (2015-2020)
• 12.4 South America Neuromuscular Disease Therapeutics Market Forecast
• 12.5 The Influence of COVID-19 on South America Market
• 12.6 South America Neuromuscular Disease Therapeutics Market Analysis by Country
  • 12.6.1 Brazil Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 12.6.2 Argentina Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 12.6.3 Columbia Neuromuscular Disease Therapeutics Sales and Growth Rate

13 Middle East and Africa Neuromuscular Disease Therapeutics Market Analysis

• 13.1 Market Overview and Prospect Analysis
• 13.2 Middle East and Africa Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)
• 13.3 Middle East and Africa Neuromuscular Disease Therapeutics Market Revenue and Growth Rate (2015-2020)
• 13.4 Middle East and Africa Neuromuscular Disease Therapeutics Market Forecast
• 13.5 The Influence of COVID-19 on Middle East and Africa Market
• 13.6 Middle East and Africa Neuromuscular Disease Therapeutics Market Analysis by Country
  • 13.6.1 UAE Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 13.6.2 Egypt Neuromuscular Disease Therapeutics Sales and Growth Rate
  • 13.6.3 South Africa Neuromuscular Disease Therapeutics Sales and Growth Rate

14 Conclusions and Recommendations

• 14.1 Key Market Findings and Prospects
• 14.2 Advice for Investors

15 Appendix

• 15.1 Methodology
• 15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Neuromuscular Disease Therapeutics Market Size and Growth Rate 2015-2025

Table Neuromuscular Disease Therapeutics Key Market Segments

Figure Global Neuromuscular Disease Therapeutics Market Revenue ($) Segment by Type from 2015-2020

Figure Global Neuromuscular Disease Therapeutics Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Neuromuscular Disease Therapeutics

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Sanofi Company Profile

Table Sanofi Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Sanofi Production and Growth Rate

Figure Sanofi Market Revenue ($) Market Share 2015-2020

Table PTC Therapeutics Inc Company Profile

Table PTC Therapeutics Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure PTC Therapeutics Inc Production and Growth Rate

Figure PTC Therapeutics Inc Market Revenue ($) Market Share 2015-2020

Table Sarepta Therapeutics Inc Company Profile

Table Sarepta Therapeutics Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Sarepta Therapeutics Inc Production and Growth Rate

Figure Sarepta Therapeutics Inc Market Revenue ($) Market Share 2015-2020

Table Biogen Inc Company Profile

Table Biogen Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Biogen Inc Production and Growth Rate

Figure Biogen Inc Market Revenue ($) Market Share 2015-2020

Table Novartis AG Company Profile

Table Novartis AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Novartis AG Production and Growth Rate

Figure Novartis AG Market Revenue ($) Market Share 2015-2020

Table Global Neuromuscular Disease Therapeutics Sales by Types (2015-2020)

Table Global Neuromuscular Disease Therapeutics Sales Share by Types (2015-2020)

Table Global Neuromuscular Disease Therapeutics Revenue ($) by Types (2015-2020)

Table Global Neuromuscular Disease Therapeutics Revenue Share by Types (2015-2020)

Table Global Neuromuscular Disease Therapeutics Price ($) by Types (2015-2020)

Table Global Neuromuscular Disease Therapeutics Market Forecast Sales by Types (2020-2025)

Table Global Neuromuscular Disease Therapeutics Market Forecast Sales Share by Types (2020-2025)

Table Global Neuromuscular Disease Therapeutics Market Forecast Revenue ($) by Types (2020-2025)

Table Global Neuromuscular Disease Therapeutics Market Forecast Revenue Share by Types (2020-2025)

Figure Global Biologics Sales and Growth Rate (2015-2020)

Figure Global Biologics Price (2015-2020)

Figure Global Small Molecules Sales and Growth Rate (2015-2020)

Figure Global Small Molecules Price (2015-2020)

Figure Global Neuromuscular Disease Therapeutics Market Revenue ($) and Growth Rate Forecast of Biologics (2020-2025)

Figure Global Neuromuscular Disease Therapeutics Sales and Growth Rate Forecast of Biologics (2020-2025)

Figure Global Neuromuscular Disease Therapeutics Market Revenue ($) and Growth Rate Forecast of Small Molecules (2020-2025)

Figure Global Neuromuscular Disease Therapeutics Sales and Growth Rate Forecast of Small Molecules (2020-2025)

Table Global Neuromuscular Disease Therapeutics Sales by Applications (2015-2020)

Table Global Neuromuscular Disease Therapeutics Sales Share by Applications (2015-2020)

Table Global Neuromuscular Disease Therapeutics Revenue ($) by Applications (2015-2020)

Table Global Neuromuscular Disease Therapeutics Revenue Share by Applications (2015-2020)

Table Global Neuromuscular Disease Therapeutics Market Forecast Sales by Applications (2020-2025)

Table Global Neuromuscular Disease Therapeutics Market Forecast Sales Share by Applications (2020-2025)

Table Global Neuromuscular Disease Therapeutics Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Neuromuscular Disease Therapeutics Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Hospital Sales and Growth Rate (2015-2020)

Figure Global Hospital Price (2015-2020)

Figure Global Research Institute Sales and Growth Rate (2015-2020)

Figure Global Research Institute Price (2015-2020)

Figure Global Others Sales and Growth Rate (2015-2020)

Figure Global Others Price (2015-2020)

Figure Global Neuromuscular Disease Therapeutics Market Revenue ($) and Growth Rate Forecast of Hospital (2020-2025)

Figure Global Neuromuscular Disease Therapeutics Sales and Growth Rate Forecast of Hospital (2020-2025)

Figure Global Neuromuscular Disease Therapeutics Market Revenue ($) and Growth Rate Forecast of Research Institute (2020-2025)

Figure Global Neuromuscular Disease Therapeutics Sales and Growth Rate Forecast of Research Institute (2020-2025)

Figure Global Neuromuscular Disease Therapeutics Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)

Figure Global Neuromuscular Disease Therapeutics Sales and Growth Rate Forecast of Others (2020-2025)

Figure Global Neuromuscular Disease Therapeutics Sales and Growth Rate (2015-2020)

Table Global Neuromuscular Disease Therapeutics Sales by Regions (2015-2020)

Table Global Neuromuscular Disease Therapeutics Sales Market Share by Regions (2015-2020)

Figure Global Neuromuscular Disease Therapeutics Sales Market Share by Regions in 2019

Figure Global Neuromuscular Disease Therapeutics Revenue and Growth Rate (2015-2020)

Table Global Neuromuscular Disease Therapeutics Revenue by Regions (2015-2020)

Table Global Neuromuscular Disease Therapeutics Revenue Market Share by Regions (2015-2020)

Figure Global Neuromuscular Disease Therapeutics Revenue Market Share by Regions in 2019

Table Global Neuromuscular Disease Therapeutics Market Forecast Sales by Regions (2020-2025)

Table Global Neuromuscular Disease Therapeutics Market Forecast Sales Share by Regions (2020-2025)

Table Global Neuromuscular Disease Therapeutics Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Neuromuscular Disease Therapeutics Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure North America Neuromuscular Disease Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure North America Neuromuscular Disease Therapeutics Market Forecast Sales (2020-2025)

Figure North America Neuromuscular Disease Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Canada Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Mexico Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Europe Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Europe Neuromuscular Disease Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure Europe Neuromuscular Disease Therapeutics Market Forecast Sales (2020-2025)

Figure Europe Neuromuscular Disease Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure France Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Italy Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Spain Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Russia Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Neuromuscular Disease Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Neuromuscular Disease Therapeutics Market Forecast Sales (2020-2025)

Figure Asia-Pacific Neuromuscular Disease Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Japan Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South Korea Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Australia Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure India Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South America Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South America Neuromuscular Disease Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure South America Neuromuscular Disease Therapeutics Market Forecast Sales (2020-2025)

Figure South America Neuromuscular Disease Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure Brazil Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Argentina Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Columbia Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Neuromuscular Disease Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Neuromuscular Disease Therapeutics Market Forecast Sales (2020-2025)

Figure Middle East and Africa Neuromuscular Disease Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure UAE Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Egypt Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South Africa Neuromuscular Disease Therapeutics Market Sales and Growth Rate (2015-2020)

Based on the Neuromuscular Disease Therapeutics market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Neuromuscular Disease Therapeutics market covered in Chapter 5:
Sanofi
PTC Therapeutics Inc
Sarepta Therapeutics Inc
Biogen Inc
Novartis AG

In Chapter 6, on the basis of types, the Neuromuscular Disease Therapeutics market from 2015 to 2025 is primarily split into:
Biologics
Small Molecules

In Chapter 7, on the basis of applications, the Neuromuscular Disease Therapeutics market from 2015 to 2025 covers:
Hospital
Research Institute
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025